GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 420 filers reported holding GUARDANT HEALTH INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $499,552 | -14.9% | 16,854 | +2.8% | 0.01% | -11.1% |
Q2 2023 | $587,156 | +94.1% | 16,401 | +27.1% | 0.01% | +80.0% |
Q1 2023 | $302,447 | -1.0% | 12,903 | +14.9% | 0.01% | 0.0% |
Q4 2022 | $305,401 | -59.6% | 11,228 | -20.1% | 0.01% | -61.5% |
Q3 2022 | $756,000 | +61.5% | 14,044 | +21.1% | 0.01% | +62.5% |
Q2 2022 | $468,000 | -33.6% | 11,596 | +9.0% | 0.01% | -20.0% |
Q1 2022 | $705,000 | -32.0% | 10,635 | +2.6% | 0.01% | -28.6% |
Q4 2021 | $1,037,000 | -30.4% | 10,370 | -12.9% | 0.01% | -33.3% |
Q3 2021 | $1,489,000 | -0.6% | 11,905 | -1.2% | 0.02% | 0.0% |
Q2 2021 | $1,498,000 | -25.1% | 12,055 | -8.0% | 0.02% | -32.3% |
Q1 2021 | $2,000,000 | +25.2% | 13,101 | +5.7% | 0.03% | +14.8% |
Q4 2020 | $1,597,000 | +8.6% | 12,391 | -5.8% | 0.03% | -6.9% |
Q3 2020 | $1,470,000 | +34.7% | 13,148 | -2.2% | 0.03% | +26.1% |
Q2 2020 | $1,091,000 | +26.0% | 13,443 | +8.0% | 0.02% | +9.5% |
Q1 2020 | $866,000 | +666.4% | 12,447 | +765.6% | 0.02% | +950.0% |
Q4 2019 | $113,000 | +156.8% | 1,438 | +108.7% | 0.00% | +100.0% |
Q3 2019 | $44,000 | -29.0% | 689 | -4.3% | 0.00% | 0.0% |
Q2 2019 | $62,000 | – | 720 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |